Table 2.

Adjusted hazard ratios (95% confidence intervals) comparing dabigatran new users to warfarin new users for the treatment of non-valvular atrial fibrillation

	Number of events			Early (<90 days)	Late (≥90 days)
	Dabigatran	Warfarin	Adjusted hazard ratio (95% CI)*	Adjusted hazard ratio (95% CI)*	Adjusted hazard ratio (95% CI)*
Intracranial bleed	15	79	0.37 (0.20, 0.67)	0.43 (0.13, 1.42)	0.34 (0.17, 0.68)
Ischemic stroke	127	369	0.65 (0.52, 0.82)	0.32 (0.22, 0.47)	0.99 (0.75, 1.31)
Myocardial infarction	115	335	0.72 (0.57, 0.91)	0.32 (0.21, 0.51)	0.99 (0.75, 1.31)
Gastrointestinal bleed	265	593	1.04 (0.88, 1.22)	1.11 (0.82, 1.51)	1.01 (0.83, 1.22)
Hip/pelvic Fracture	108	275	1.02 (0.80, 1.30)	0.52 (0.28, 0.97)	1.16 (0.88, 1.51)

^*Adjusted for age, sex, CHADS₂ score, and propensity score decile